» Articles » PMID: 31898535

HIV Virological Non-suppression and Factors Associated with Non-suppression Among Adolescents and Adults on Antiretroviral Therapy in Northern Ethiopia: a Retrospective Study

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2020 Jan 4
PMID 31898535
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite the benefits of Antiretroviral Therapy (ART), there is a growing concern of treatment failure. This study aimed to assess viral non suppression rate and factors associated with HIV viral non suppression among adolescents and adults on ART in Northern Ethiopia.

Methods: A retrospective cross sectional study was done on 19,525 study subjects. All the data in the database of Tigray Health Research Institute was exported to Microsoft excel 2010 and then data verification and filtration were done before exporting to STATA 14.0 for analysis. Generalized Estimating Equation (GEE) logistic regression was used for statistical modeling of viral non suppression.

Results: A total of 5153 (26.39%; 95%CI (25.77%, 27.02)) patients had no viral suppression despite being on ART. Being male (AOR = 1.27, 95% CI: 1.18, 1.37), 15-19 years of age (AOR = 4.86, 95%CI: 3.86, 6.12), patients from primary hospital (AOR = 1.26, 95%CI: 1.05, 1.52), WHO staging II (AOR = 1.31, 95%CI: 1.10, 1.54), poor ART adherence level (AOR = 2.56, 95%CI: 1.97, 3.33), fair ART adherence level (AOR = 1.61, 95%CI: 1.36, 1.90), baseline CD-4 count of < 200 cells/micro liter (AOR = 1.33, 95%CI: 1.14, 1.54), recent CD-4 count of < 200 cells/micro liter (AOR = 3.78, 95%CI: 3.34, 4.27), regimen types: 1c (AZT-3TC-NVP) (AOR = 1.32, 95%CI: 1.22, 1.44), 2 h (TDF-3TC-ATV/R) (AOR = 1.79, 95%CI: 1.27, 2.52) and declined immunological responses after ART initiation (AOR = 1.45, 95%CI: 1.30, 1.61) were significantly associated with viral non-suppression.

Conclusions: The virological non suppression was high which makes it less likely to achieve the third 90 UNAIDS target. Being male, patients with WHO staging II and poor ART adherence level were significantly associated with viral non suppression. Therefore, intensive adherence support and counseling should be provided. It is also a high time to determine the antiretroviral drugs resistance pattern given the fact that a large number of patients had virological non suppression.

Citing Articles

Impact of differentiated care service delivery systems on adherence among the HIV-positive patients receiving antiretroviral therapy in a Southeastern Nigerian State.

Ekwuofu A, Dim O, Adibe M AIDS Res Ther. 2025; 22(1):32.

PMID: 40065394 PMC: 11895224. DOI: 10.1186/s12981-024-00671-y.


Virological outcomes of antiretroviral therapy and its determinants among HIV patients in Ethiopia: Implications for achieving the 95-95-95 target.

Kitaw T, Haile R PLoS One. 2025; 20(1):e0313481.

PMID: 39746073 PMC: 11694995. DOI: 10.1371/journal.pone.0313481.


Risk Factors for Viral Non-suppression Among Youth Living with HIV in Nigeria: Findings from the iCARE Nigeria Study.

Balogun M, Kuhns L, Akanmu A, Garofalo R, Badru T, Adekanmbi A AIDS Behav. 2024; 29(3):848-857.

PMID: 39652275 DOI: 10.1007/s10461-024-04565-y.


Virological failure and associated factors among patients receiving anti-retroviral therapy in Ethiopia: A systematic review and meta-analysis.

Aytenew T, Asferie W, Ejigu N, Birhane B, Tiruneh Y, Kassaw A BMJ Open. 2024; 14(11):e087569.

PMID: 39613423 PMC: 11605831. DOI: 10.1136/bmjopen-2024-087569.


Social support, gender and pill burden influence viral load suppression among HIV-infected adolescents and young adults in rural south-western Uganda.

Brown W, Malagala H, Bajunirwe F Vulnerable Child Youth Stud. 2024; 16(1):86-97.

PMID: 39544698 PMC: 11563049. DOI: 10.1080/17450128.2020.1842954.


References
1.
Ayele G, Tessema B, Amsalu A, Ferede G, Yismaw G . Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia. BMC Immunol. 2018; 19(1):37. PMC: 6296084. DOI: 10.1186/s12865-018-0278-4. View

2.
Clavel F, Hance A . HIV drug resistance. N Engl J Med. 2004; 350(10):1023-35. DOI: 10.1056/NEJMra025195. View

3.
Obiri-Yeboah D, Pappoe F, Baidoo I, Arthur F, Hayfron-Benjamin A, Essien-Baidoo S . Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana. BMC Infect Dis. 2018; 18(1):230. PMC: 5963173. DOI: 10.1186/s12879-018-3142-5. View

4.
Bennett D, Bertagnolio S, Sutherland D, Gilks C . The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir Ther. 2008; 13 Suppl 2:1-13. View

5.
Bayu B, Tariku A, Bulti A, Habitu Y, Derso T, Teshome D . Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case-control study. HIV AIDS (Auckl). 2017; 9:153-159. PMC: 5557910. DOI: 10.2147/HIV.S139516. View